Cargando…
Are We Prepared for the CDK4/6 Revolution With HR+/HER2− Breast Cancers?: The Importance of Patient Adherence to Adjuvant Therapies
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685741/ https://www.ncbi.nlm.nih.gov/pubmed/38034323 http://dx.doi.org/10.1177/11782234231215192 |
| _version_ | 1785151698011947008 |
|---|---|
| author | Azoz, Seyla Peters, Martin Jones, Graham |
| author_facet | Azoz, Seyla Peters, Martin Jones, Graham |
| author_sort | Azoz, Seyla |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10685741 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | SAGE Publications |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106857412023-11-30 Are We Prepared for the CDK4/6 Revolution With HR+/HER2− Breast Cancers?: The Importance of Patient Adherence to Adjuvant Therapies Azoz, Seyla Peters, Martin Jones, Graham Breast Cancer (Auckl) Letter to the Editor SAGE Publications 2023-11-28 /pmc/articles/PMC10685741/ /pubmed/38034323 http://dx.doi.org/10.1177/11782234231215192 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
| spellingShingle | Letter to the Editor Azoz, Seyla Peters, Martin Jones, Graham Are We Prepared for the CDK4/6 Revolution With HR+/HER2− Breast Cancers?: The Importance of Patient Adherence to Adjuvant Therapies |
| title | Are We Prepared for the CDK4/6 Revolution With HR+/HER2− Breast Cancers?: The Importance of Patient Adherence to Adjuvant Therapies |
| title_full | Are We Prepared for the CDK4/6 Revolution With HR+/HER2− Breast Cancers?: The Importance of Patient Adherence to Adjuvant Therapies |
| title_fullStr | Are We Prepared for the CDK4/6 Revolution With HR+/HER2− Breast Cancers?: The Importance of Patient Adherence to Adjuvant Therapies |
| title_full_unstemmed | Are We Prepared for the CDK4/6 Revolution With HR+/HER2− Breast Cancers?: The Importance of Patient Adherence to Adjuvant Therapies |
| title_short | Are We Prepared for the CDK4/6 Revolution With HR+/HER2− Breast Cancers?: The Importance of Patient Adherence to Adjuvant Therapies |
| title_sort | are we prepared for the cdk4/6 revolution with hr+/her2− breast cancers?: the importance of patient adherence to adjuvant therapies |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685741/ https://www.ncbi.nlm.nih.gov/pubmed/38034323 http://dx.doi.org/10.1177/11782234231215192 |
| work_keys_str_mv | AT azozseyla arewepreparedforthecdk46revolutionwithhrher2breastcancerstheimportanceofpatientadherencetoadjuvanttherapies AT petersmartin arewepreparedforthecdk46revolutionwithhrher2breastcancerstheimportanceofpatientadherencetoadjuvanttherapies AT jonesgraham arewepreparedforthecdk46revolutionwithhrher2breastcancerstheimportanceofpatientadherencetoadjuvanttherapies |